Matthew Cozzolino

Matthew Cozzolino

Auto-generated profile, based on publicly available information

Matthew Cozzolino

Section of Cardiovascular Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine , Boston, MA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2023 in Chest
Verified
Journal Article
Closed access
JLJustin K. Lui
Justin K. Lui
MCMatthew Cozzolino
Matthew Cozzolino
MWMorgan Winburn
Morgan Winburn
MTMarcin A. Trojanowski
Marcin A. Trojanowski
RWRenda Soylemez Wiener
Renda Soylemez Wiener
EKElizabeth S. Klings
Elizabeth S. Klings

31 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJustin K. Lui
Justin K. Lui
FEFatima El-Adili
Fatima El-Adili
MCMatthew Cozzolino
Matthew Cozzolino
MWMorgan Winburn
Morgan Winburn
MTMarcin A. Trojanowski
Marcin A. Trojanowski
ABAndreea M. Bujor
Andreea M. Bujor
Objective: We sought to investigate the relationship between serum biomarkers of cardiac dysfunction, longitudinal strain on echocardiography, and all-cause mortality in patients with systemic sclerosis. Methods: This was an observational study using a biorepository of serum samples of patients with systemic sclerosis who underwent echocardiography. We investigated 3 biomarkers: periostin, galectin-3, and N-terminal prohormone brain natriuretic peptide and applied a K-means clustering resulting in 3 patient clusters. We subsequently measured left ventricular and right ventricular free wall longitudinal strain in each cluster. We then determined the association between each cluster and time to all-cause mortality compared to N-terminal prohormone brain natriuretic peptide, alone. Results: The 125 patients with systemic sclerosis included in the study were divided into 3 clusters based on biomarker levels (Cluster 1: N = 75; Cluster 2: N = 39; Cluster 3: N = 11). Compared to Cluster 1, Cluster 2 had only elevated periostin levels whereas Cluster 3 had elevated levels of all 3 serum biomarkers and was characterized by reduced left ventricular and right ventricular free wall longitudinal strain, regionally and globally. When adjusted for age, sex, systemic sclerosis disease duration, and forced vital capacity, patients in Cluster 3 had a HR of 14.42 (95% CI: 4.82, 43.18) for all-cause mortality compared to those in Cluster 1. Conclusion: In conclusion, combining N-terminal prohormone brain natriuretic peptide, periostin, and galectin-3 as serum biomarkers enhances risk stratification and sensitivity in detection of cardiac disease in patients with systemic sclerosis. However, before implementation in routine care, further prospective studies must refine biomarker sensitivity, specificity, and accuracy together with optimizing detection strategies and establishing clinical protocols for integration.

30 January 2026 in Rheumatology
Verified
Journal Article
Closed access
JLJustin K Lui
Justin K Lui
MCMatthew Cozzolino
Matthew Cozzolino
MWMorgan Winburn
Morgan Winburn
MTMarcin A Trojanowski
Marcin A Trojanowski
MLMichael P LaValley
Michael P LaValley
EKElizabeth S Klings
Elizabeth S Klings
Objectives: The objective of the study was to explore left atrial (LA) strain, a quantitative index of left ventricular (LV) diastolic function, in risk stratifying patients with SSc-related pulmonary hypertension (SSc-PH). Methods: This was an exploratory, retrospective single-centre study of 124 patients with SSc-PH confirmed on right heart catheterization. We quantified and clustered the three components of LA global longitudinal strain (GLS): (i) reservoir (systole); (ii) conduit (early diastole); and (iii) contractile (late diastole), using echocardiograms closest to timing of right heart catheterization. We applied both the Kaplan–Meier method and a Cox proportional hazards model to determine associations with our primary outcome of all-cause mortality. Results: Using k-means clustering, we divided our cohort into three clusters: Cluster 1 (N = 40), Cluster 2 (N = 34) and Cluster 3 (N = 50). Compared with Cluster 1, Cluster 2 had the lowest median LA conduit strain, and Cluster 3 exhibited the lowest median LA contractile strain. There was a statistically significant difference in survival between clusters (log-rank P = 0.005). Median survival was 122.4 months, 67.9 months and 48.4 months for Cluster 1, Cluster 2 and Cluster 3, respectively. Compared with those in Cluster 1, patients in Cluster 2 and Cluster 3 had adjusted hazard ratios of 1.46 (95% CI: 0.71, 2.97) and 2.57 (95% CI: 1.32, 5.02) for all-cause mortality, respectively. Conclusion: Of the three LA GLS clusters, Cluster 3 had the shortest median survival. LA GLS may provide further risk stratification of patients with SSc-PH.

1 May 2021 in JACC
Verified
Journal Article
Closed access
MCMatthew Cozzolino
Matthew Cozzolino
RARabah Alreshq
Rabah Alreshq
BLBrian Lilleness
Brian Lilleness
APAlexandra Pipilas
Alexandra Pipilas
VMVarsha Muralidhar
Varsha Muralidhar
FRFrederick Ruberg
Frederick Ruberg